Review



microarray  (SuperArray Bioscience Corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    SuperArray Bioscience Corporation microarray
    Microarray, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/customised+oligonucleotide+microarray/microarray/10__1515_slash_jib___2007___78-291-26-34
    Average 90 stars, based on 1 article reviews
    microarray - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Suppressive effect of Siraitia grosvenorii extract on dicyclanil-promoted hepatocellular proliferative lesions in male mice.
    Article Snippet: A list of all genes in this microarray is available on the web site (http:// www.superarray.com/gene_array_product/HTML/ MM-012.html).

    Article Title: Semi-allogeneic vaccine for T-cell lymphoma
    Article Snippet: Scatter plot comparisons were performed in a blinded fashion by the microarray manufacturer (Superarray Bioscience Corp.), and included only genes that showed either up-regulation or down-regulation by 1.5 fold or more.

    Article Title: Autocrine motility-stimulatory pathways of oral premalignant lesion cells.
    Article Snippet: Premalignant lesion expression of IL-10 In a hematology/immunology microarray (SuperArray Bioscience Corp., Frederick, MD) that we previously performed on premalignant oral lesion tissues with various levels of dysplasia, the most prominent difference between oral lesions with no dysplasia and those with dysplasia was in expression of IL-10.

    Article Title: Methods of modulating erythropoiesis with arginine vasopressin receptor 1B molecules
    Article Snippet: In a single microarray study of Wnt pathway activation (Superarray, SA Biosciences) an over two-fold difference in a number of genes was observed following AVP stimulation of CD34+ cells, such as CDON, DKK1, DPP10, FZD7 (upregulated) and CDKN2A, FST and KLF5 (down-regulated).

    Article Title: Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression
    Article Snippet: TranSignal Protein/DNA Microarray I (SuperArray, Bethesda, MD) was used to characterize the transcription factor profiles of SMMC-7721 and HCCLM6 cells.

    Microarray:

    Article Title: Modulation of stress genes expression profile by nitric oxide-releasing aspirin in Jurkat T leukemia cells.
    Article Snippet: NO-donating aspirin (NO-ASA, para isomer) has been reported to exhibit strong growth inhibitory effect in Jurkat T-acute lymphoblastic leukemia (T-ALL) cells mediated in part by b-catenin degradation and caspase activation, but the mechanism(s) still remains unclear.. In this study, DNA oligoarrays with 263 genes were used to examine the gene expression profiles relating to stress and drug metabolism, and characterize the stress responses at IC50 and subIC50 concentrations of p-NO-ASA (20 and 10 mM, respectively) in Jurkat T cells.. A total of 22 genes related to heat shock response, apoptosis signaling, detoxifiers and Phase II enzymes, and regulators of cell growth were altered in expression by array analysis based on the expression fold change criteria of 1.5-fold or 0.65-fold.

    Article Title: CIDA: An integrated software for the design, characterisation and global comparison of microarrays
    Article Snippet: .. With respect to the customised gene chip design aspect of our software, whilst many commercial microarray services are available (Affymetrix Custom Array Design Program [46], the Keck DNA Microarray Resource [47], Combimatrix [48] and SuperArray [17] they do not provide a public software for the creation and will not be able to process your design without a purchase order for their array chips. ..

    Article Title: In vivo effect of alpha-bisabolol, a nontoxic sesquiterpene alcohol, on the induction of spontaneous mammary tumors in HER-2/neu transgenic mice.
    Article Snippet: *Center on Nutrition and Ageing, INRCA, Ancona, Italy †Experimental Animal Models for Ageing Unit, INRCA, Ancona, Italy ‡Department of Neuroscience and Vision, Section of Biochemistry, University of Verona, Verona, Italy §Department of Medicine and Public Health, University of Verona, Verona, Italy ¶Department of Molecular Pathology and Innovative Therapies, Occupational Medicine, Polytechnic University of Marche, Torrette, Ancona, Italy #Institute for Biochemical Biotechnologies, Polytechnic University of Marche, Ancona, Italy

    Software:

    Article Title: CIDA: An integrated software for the design, characterisation and global comparison of microarrays
    Article Snippet: .. With respect to the customised gene chip design aspect of our software, whilst many commercial microarray services are available (Affymetrix Custom Array Design Program [46], the Keck DNA Microarray Resource [47], Combimatrix [48] and SuperArray [17] they do not provide a public software for the creation and will not be able to process your design without a purchase order for their array chips. ..



    Similar Products

    customised oligonucleotide microarray  (Agilent technologies)
    90
    Agilent technologies customised oligonucleotide microarray
    Customised Oligonucleotide Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/customised+oligonucleotide+microarray/pm25195018-60-10-12
    Average 90 stars, based on 1 article reviews
    customised oligonucleotide microarray - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    customised 11 kb oligonucleotide-microarray  (Agilent technologies)
    90
    Agilent technologies customised 11 kb oligonucleotide-microarray
    Relative expression levels of GATA-4 and friend-of-GATA ( FOG )-2 according to <t>microarray</t> analyses. ( A – D ) GATA-4 and ( E – H ) FOG-2 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =32 for GATA-4 ; n =33 for FOG-2 ). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Boxes: median expression values (horizontal line) and twenty-fifth and seventy-fifth percentiles; whiskers: distances from the end of the box to the largest and smallest observed values that are <1.5 box lengths from either end of the box; open circles: outlying values; asterisks: extreme values. ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.
    Customised 11 Kb Oligonucleotide Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/customised+oligonucleotide+microarray/pmc02768442-36-29-31
    Average 90 stars, based on 1 article reviews
    customised 11 kb oligonucleotide-microarray - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Relative expression levels of GATA-4 and friend-of-GATA ( FOG )-2 according to microarray analyses. ( A – D ) GATA-4 and ( E – H ) FOG-2 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =32 for GATA-4 ; n =33 for FOG-2 ). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Boxes: median expression values (horizontal line) and twenty-fifth and seventy-fifth percentiles; whiskers: distances from the end of the box to the largest and smallest observed values that are <1.5 box lengths from either end of the box; open circles: outlying values; asterisks: extreme values. ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.

    Journal: British Journal of Cancer

    Article Title: GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes

    doi: 10.1038/sj.bjc.6605276

    Figure Lengend Snippet: Relative expression levels of GATA-4 and friend-of-GATA ( FOG )-2 according to microarray analyses. ( A – D ) GATA-4 and ( E – H ) FOG-2 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =32 for GATA-4 ; n =33 for FOG-2 ). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Boxes: median expression values (horizontal line) and twenty-fifth and seventy-fifth percentiles; whiskers: distances from the end of the box to the largest and smallest observed values that are <1.5 box lengths from either end of the box; open circles: outlying values; asterisks: extreme values. ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.

    Article Snippet: In brief, 1 μ g of linearly amplified Cy3- and Cy5-labelled cRNA was hybridised together with 1 μ g of reverse colour Cy-labelled reference cRNA to a customised 11 kb oligonucleotide-microarray (Agilent Technologies, Waldbronn, Germany).

    Techniques: Expressing, Microarray, Amplification, MANN-WHITNEY

    Relative expression levels of GATA-2 and -3 according to microarray analyses. ( A – D ) GATA-2 and ( E – H ) GATA-3 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =33). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Box plots represent data as in . * P <0.05; ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.

    Journal: British Journal of Cancer

    Article Title: GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes

    doi: 10.1038/sj.bjc.6605276

    Figure Lengend Snippet: Relative expression levels of GATA-2 and -3 according to microarray analyses. ( A – D ) GATA-2 and ( E – H ) GATA-3 . ( A and E ) MYCN -nonamplified ( n =218) vs MYCN -amplified ( n =33). ( B and F ) Localised stages ( n =153) vs stage 4 ( n =67) vs stage 4S ( n =31). ( C and G ) Patients below 1 year ( n =94) vs above 1 year ( n =157). ( D and H ) High-risk (HR; n =82) vs low-risk (LR; n =169) tumours according to the PAM classification. Expression values are given in log ratios (sample vs reference RNA). Box plots represent data as in . * P <0.05; ** P <0.01; *** P <0.001 according to the nonparametric Mann–Whitney test.

    Article Snippet: In brief, 1 μ g of linearly amplified Cy3- and Cy5-labelled cRNA was hybridised together with 1 μ g of reverse colour Cy-labelled reference cRNA to a customised 11 kb oligonucleotide-microarray (Agilent Technologies, Waldbronn, Germany).

    Techniques: Expressing, Microarray, Amplification, MANN-WHITNEY